Nitta Gelatin expands Wellnex Replenwell collagen peptide line-up with ASC-certified fish collagen peptides
December 12, 2022
Traceable. Transparent. Trustworthy. Nitta Gelatin North America is proud to offer clinically tested freshwater fish collagen peptide ingredients independently certified to the Aquaculture Stewardship Council (ASC) standards.
Gelita uses SupplySide West to showcase how its bioactive collagen peptides, gelatins fit a wide range of functional formulations
October 20, 2022
GELITA welcomes SupplySide West visitors to “Take the Challenge” at Booth #4465 as GELITA showcases mobility solutions, delivery formats and BCP® solutions for health and nutrition formulations. GELITA also will introduce its next-generation gelatin for sugar-reduced, protein-enriched, and beauty gummies.
Gelita using SupplySide West to showcase bioactive collagen peptides, gelatin in better-for-you functional applications
October 14, 2021
GELITA will be live at SupplySide West, Booth #4665, to present its roster of Bioactive Collagen Peptides (BCP®) and the GELITA Controlled Release Portfolio. Gelita’s team strategists will help formulators discover solutions for health and nutrition formulations.
GELITA returns as “Official Collagen Protein Sponsor” of SupplySide West
September 17, 2019
Collagen, a major component of the human body, is a primary structural protein of connective tissues and supports musculoskeletal function and performance. With so much attention on the sports nutrition arena, GELITA’s roster of Bioactive Collagen Peptides® is sure to be Most Valuable Player at SupplySide West (SSW).
Through a pioneering licensing deal, Dolcas makes this uniquely efficacious “beauty-from-within” ingredient available to US consumers at a low, clinically supported daily dose of just 1g. Morikol will be featured at this year’s SSW Expo in Las Vegas, Booth #6675.
Nuritas will place new funding toward continued development of bioactive peptides through artificial intelligence and genomics
December 21, 2017
This brings the total invested to date to approximately $30 million, including early funding from U2's Bono and The Edge, Salesforce CEO Marc Benioff, Singapore-based VisVires New Protein and angel investor Ali Partovi.